CLDX CELLDEX THERAPEUTICS INC NEW More: the full row for CELLDEX THERAPEUTICS INC NEW Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 865,000 shares; 2026Q1: 865,000 shares; 2026Q2: 990,000 shares; 2026Q3: 1,110,000 shares 1,110,000 $36M 8.91% +120,000 Timeline LEGN LEGEND BIOTECH CORP More: the full row for LEGEND BIOTECH CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 570,569 shares; 2026Q3: 1,569,676 shares 1,569,676 $31.2M 7.73% +999,107 Timeline SNDX SYNDAX PHARMACEUTICALS INC More: the full row for SYNDAX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 1,855,000 shares; 2026Q1: 1,855,000 shares; 2026Q2: 1,855,000 shares; 2026Q3: 1,605,000 shares 1,605,000 $30.2M 7.47% -250,000 Timeline COGT COGENT BIOSCIENCES INC More: the full row for COGENT BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 1,170,740 shares; 2026Q1: 1,170,740 shares; 2026Q2: 1,170,740 shares; 2026Q3: 866,742 shares 866,742 $27.8M 6.87% -303,998 Timeline RLAY RELAY THERAPEUTICS INC More: the full row for RELAY THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 536,946 shares; 2026Q1: 536,946 shares; 2026Q2: 1,465,279 shares; 2026Q3: 1,465,279 shares 1,465,279 $26.4M 6.55% 0 Timeline AMLX AMYLYX PHARMACEUTICALS INC More: the full row for AMYLYX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 112,000 shares; 2026Q1: 112,000 shares; 2026Q2: 112,000 shares; 2026Q3: 894,760 shares 894,760 $26M 6.45% +782,760 Timeline VRDN VIRIDIAN THERAPEUTICS INC More: the full row for VIRIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 858,631 shares; 2026Q1: 534,931 shares; 2026Q2: 984,931 shares; 2026Q3: 1,224,931 shares 1,224,931 $25.2M 6.25% +240,000 Timeline PCVX VAXCYTE INC More: the full row for VAXCYTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 291,500 shares; 2026Q1: 316,500 shares; 2026Q2: 452,340 shares; 2026Q3: 372,340 shares 372,340 $21.2M 5.25% -80,000 Timeline URGN UROGEN PHARMA LTD More: the full row for UROGEN PHARMA LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 100,000 shares; 2026Q1: 220,000 shares; 2026Q2: 120,000 shares; 2026Q3: 491,100 shares 491,100 $20M 4.94% +371,100 Timeline TVTX TRAVERE THERAPEUTICS INC More: the full row for TRAVERE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 110,000 shares; 2026Q1: 177,600 shares; 2026Q2: 292,600 shares; 2026Q3: 322,600 shares 322,600 $19M 4.7% +30,000 Timeline CGEM CULLINAN THERAPEUTICS INC More: the full row for CULLINAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 310,000 shares; 2026Q1: 530,000 shares; 2026Q2: 690,000 shares; 2026Q3: 962,792 shares 962,792 $14.8M 3.66% +272,792 Timeline PHVS PHARVARIS N V More: the full row for PHARVARIS N V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 475,750 shares; 2026Q1: 475,750 shares; 2026Q2: 525,750 shares; 2026Q3: 455,750 shares 455,750 $14.5M 3.58% -70,000 Timeline VERA VERA THERAPEUTICS INC More: the full row for VERA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 482,500 shares; 2026Q1: 482,500 shares; 2026Q2: 436,518 shares; 2026Q3: 436,518 shares 436,518 $14.1M 3.49% 0 Timeline CTMX CYTOMX THERAPEUTICS INC. More: the full row for CYTOMX THERAPEUTICS INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 700,000 shares; 2026Q1: 4,550,000 shares; 2026Q2: 4,550,000 shares; 2026Q3: 4,550,000 shares 4,550,000 $12.4M 3.06% 0 Timeline BEAM BEAM THERAPEUTICS INC More: the full row for BEAM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 476,338 shares; 2026Q1: 476,338 shares; 2026Q2: 476,338 shares; 2026Q3: 476,338 shares 476,338 $11.6M 2.88% 0 Timeline NRIX NURIX THERAPEUTICS INC More: the full row for NURIX THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 460,000 shares; 2026Q1: 460,000 shares; 2026Q2: 460,000 shares; 2026Q3: 460,000 shares 460,000 $10.9M 2.7% 0 Timeline SMMT SUMMIT THERAPEUTICS INC More: the full row for SUMMIT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 493,820 shares; 2026Q3: 493,820 shares 493,820 $8.35M 2.07% 0 Timeline UTHR UNITED THERAPEUTICS CORP DEL More: the full row for UNITED THERAPEUTICS CORP DEL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 11,000 shares; 2026Q1: 15,000 shares; 2026Q2: 15,000 shares; 2026Q3: 15,000 shares 15,000 $8.13M 2.01% 0 Timeline IMCR IMMUNOCORE HLDGS PLC More: the full row for IMMUNOCORE HLDGS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 58,248 shares; 2026Q1: 58,248 shares; 2026Q2: 81,143 shares; 2026Q3: 256,143 shares 256,143 $7.76M 1.92% +175,000 Timeline KRYS KRYSTAL BIOTECH INC More: the full row for KRYSTAL BIOTECH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 22,000 shares; 2026Q1: 22,000 shares; 2026Q2: 22,000 shares; 2026Q3: 22,000 shares 22,000 $7.32M 1.81% 0 Timeline ALMS ALUMIS INC More: the full row for ALUMIS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 130,000 shares; 2026Q2: 130,000 shares; 2026Q3: 749,560 shares 749,560 $5.54M 1.37% +619,560 Timeline BCRX BIOCRYST PHARMACEUTICALS INC More: the full row for BIOCRYST PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 2,150,000 shares; 2026Q1: 1,000,000 shares; 2026Q2: 520,000 shares; 2026Q3: 520,000 shares 520,000 $4.33M 1.07% 0 Timeline STRO SUTRO BIOPHARMA INC More: the full row for SUTRO BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 32,037 shares; 2026Q3: 228,265 shares 228,265 $3.68M 0.91% +196,228 Timeline MBX MBX BIOSCIENCES INC More: the full row for MBX BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 211,000 shares; 2026Q1: 211,000 shares; 2026Q2: 91,000 shares; 2026Q3: 61,000 shares 61,000 $3.58M 0.89% -30,000 Timeline DBVT DBV TECHNOLOGIES S A More: the full row for DBV TECHNOLOGIES S A Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 265,000 shares; 2026Q2: 265,000 shares; 2026Q3: 265,000 shares 265,000 $3.12M 0.77% 0 Timeline SUPN SUPERNUS PHARMACEUTICALS More: the full row for SUPERNUS PHARMACEUTICALS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 20,000 shares; 2026Q1: 20,000 shares; 2026Q2: 70,000 shares; 2026Q3: 70,000 shares 70,000 $3.01M 0.75% 0 Timeline BMRN BIOMARIN PHARMACEUTICAL INC More: the full row for BIOMARIN PHARMACEUTICAL INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 82,000 shares; 2026Q1: 47,000 shares; 2026Q2: 47,000 shares; 2026Q3: 47,000 shares 47,000 $2.82M 0.7% 0 Timeline SEPN SEPTERNA INC More: the full row for SEPTERNA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 49,444 shares; 2026Q3: 49,444 shares 49,444 $1.93M 0.48% 0 Timeline ALEC ALECTOR INC More: the full row for ALECTOR INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 900,000 shares; 2026Q1: 900,000 shares; 2026Q2: 900,000 shares; 2026Q3: 915,902 shares 915,902 $1.69M 0.42% +15,902 Timeline DSGN DESIGN THERAPEUTICS INC More: the full row for DESIGN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 207,900 shares; 2026Q1: 207,900 shares; 2026Q2: 107,900 shares; 2026Q3: 107,900 shares 107,900 $1.36M 0.34% 0 Timeline